TFFP TFF Pharmaceuticals Quick Ratio

TFF Pharmaceuticals specializes in an innovative thin-film freezing method that converts injectable drugs into an inhalable powder form, simplifying transportation. Demand for such B2B solutions remains stable, driving an increase in the number of global partners. This price chart, where the metric stands at 0.87, clearly illustrates the price action accompanying a transparent business wind-down and the liquidation of patents due to a lack of funds.

Investors use this indicator to assess the issuer's ability to instantaneously settle short-term obligations without liquidating inventory. The calculation is based on the sum of cash and accounts receivable, excluding low-liquidity assets. The trend of the absolute liquidity ratio reflects the real solvency of TFF Pharmaceuticals (TFFP). For a company whose valuation relies on patents and clinical cycles, such reserves are critical during the development of new drug delivery technologies.